Novel blood test identifies Alzheimer’s risk with 97% accuracy
Drug Discovery World
OCTOBER 18, 2023
A new blood test has been shown to identify biomarkers for Alzheimer’s disease, providing an early warning of cognitive decline. Early results from PharmaKure, a pharmaceutical company spun out from The University of Manchester, UK, shows a novel whole blood test (ALZmetrix) developed by the company can quantify Alzheimer’s disease biomarkers. The test may enable the development of a screening system to catch Alzheimer’s before any major memory problems become apparent, allowing treatments to be
Let's personalize your content